Fig. 1From: Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case reportDisease status before and after neoadjuvant osimertinib therapy. Positron emission tomography/computed tomography at diagnosis. a Right lower lobe pulmonary nodule measuring 17 × 15 mm with maximum standardized uptake value (SUVmax) of 7.6. b Prominent right paratracheal lymph node measuring up to 13 mm in the short axis with SUVmax of 12.9Back to article page